These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12781188)

  • 21. Enediyne-mediated cleavage of RNA.
    Battigello JM; Cui M; Roshong S; Carter BJ
    Bioorg Med Chem; 1995 Jun; 3(6):839-49. PubMed ID: 7582960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The proteolytic specificity of the natural enediyne-containing chromoproteins is unique to each chromoprotein.
    Zein N; Reiss P; Bernatowicz M; Bolgar M
    Chem Biol; 1995 Jul; 2(7):451-5. PubMed ID: 9383447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of cyclic enediynes related to dynemicin A. I. Synthesis and antitumor activity of 9-acetoxy enediynes equipped with aryl carbamate moieties.
    Unno R; Michishita H; Inagaki H; Suzuki Y; Baba Y; Jomori T; Nishikawa T; Isobe M
    Bioorg Med Chem; 1997 May; 5(5):883-901. PubMed ID: 9208100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA microstructural requirements for neocarzinostatin chromophore-induced direct strand cleavage.
    Lee SH; Thivierge JO; Goldberg IH
    Nucleic Acids Res; 1989 Jul; 17(14):5809-25. PubMed ID: 2527356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of succinyl neocarzinostatin in vivo.
    Maeda H; Ichimura H; Satoh H; Ohtsuki K
    J Antibiot (Tokyo); 1978 May; 31(5):468-72. PubMed ID: 149781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replication block by an enediyne drug-DNA deoxyribose adduct.
    Kappen LS; Goldberg IH
    Biochemistry; 1999 Jan; 38(1):235-42. PubMed ID: 9890903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor activity of water-soluble enediyne compounds related to dynemicin A.
    Unno R; Michishita H; Inagaki H; Suzuki Y; Baba Y; Jomori T; Nishikawa T; Isobe M
    Bioorg Med Chem; 1997 May; 5(5):987-99. PubMed ID: 9208107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyribonucleic acid damage by neocarzinostatin chromophore: strand breaks generated by selective oxidation of C-5' of deoxyribose.
    Kappen LS; Goldberg IH
    Biochemistry; 1983 Oct; 22(21):4872-8. PubMed ID: 6227335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of activation of the antitumor antibiotic neocarzinostatin by mercaptan and sodium borohydride.
    Hensens OD; Goldberg IH
    J Antibiot (Tokyo); 1989 May; 42(5):761-8. PubMed ID: 2524463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradation of HeLa cell chromatin by neocarzinostatin and its chromophore.
    McHugh MM; Woynarowski J; Beerman T
    Biochim Biophys Acta; 1982 Jan; 696(1):7-14. PubMed ID: 6211192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
    Napier MA; Goldberg IH
    Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced formation of a DNA bulge structure by a molecular wedge ligand-postactivated neocarzinostatin chromophore.
    Gao X; Stassinopoulos A; Ji J; Kwon Y; Bare S; Goldberg IH
    Biochemistry; 2002 Apr; 41(16):5131-43. PubMed ID: 11955061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neocarzinostatin induces neuronal morphology of mouse neuroblastoma in culture.
    Schor NF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):906-10. PubMed ID: 2525186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Light-induced DNA cleavage by esperamicin and neocarzinostatin.
    Uesawa Y; Kuwahara J; Sugiura Y
    Biochem Biophys Res Commun; 1989 Oct; 164(2):903-11. PubMed ID: 2554905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NMR studies of the post-activated neocarzinostatin chromophore-DNA complex. Conformational changes induced in drug and DNA.
    Gao X; Stassinopoulos A; Gu J; Goldberg IH
    Bioorg Med Chem; 1995 Jun; 3(6):795-809. PubMed ID: 7582957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconstitution of neocarzinostatin (NCS).
    Koide Y; Ito A; Ishii F; Koyama Y; Edo K; Ishida N
    J Antibiot (Tokyo); 1982 Jun; 35(6):766-9. PubMed ID: 6214537
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of target selection by DNA-damaging chemicals: studies with enediyne anticancer drugs.
    Dedon PC
    Int Arch Occup Environ Health; 1996; 68(6):408-14. PubMed ID: 8891777
    [No Abstract]   [Full Text] [Related]  

  • 39. Asymmetric synthesis and cytotoxicity of (-)-saframycin A analogues.
    Dong W; Liu W; Yan Z; Liao X; Guan B; Wang N; Liu Z
    Eur J Med Chem; 2012 Mar; 49():239-44. PubMed ID: 22284268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of apoptosis in leukemic cells by analogs of dynemicin A.
    Hiatt A; Merlock R; Mauch S; Wrasidlo W
    Bioorg Med Chem; 1994 May; 2(5):315-22. PubMed ID: 7922142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.